Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Page 1
Influence of preoperative frailty on quality of life after cardiac surgery: A systematic review and meta-analysis.
Fehlmann CA, Bezzina K, Mazzola R, Visintini SM, Guo MH, Rubens FD, Wells GA, McGuinty C, Huang A, Khoury L, Boczar KE. Fehlmann CA, et al. Among authors: wells ga. J Am Geriatr Soc. 2023 Oct;71(10):3278-3286. doi: 10.1111/jgs.18454. Epub 2023 Jun 8. J Am Geriatr Soc. 2023. PMID: 37289174 Review.
The primary outcome was patient's perceived change in QoL following cardiac surgery. Secondary outcomes included residing in a long-term care facility for 1 year, readmission in the year following the intervention, and discharge destination. ...
The primary outcome was patient's perceived change in QoL following cardiac surgery. Secondary outcomes included residing in a long-term …
Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
Chih S, Chong AY, Džavík V, So DY, Aleksova N, Wells GA, Bernick J, Overgaard CB, Stadnick E, Mielniczuk LM, Beanlands RSB, Ross HJ. Chih S, et al. Among authors: wells ga. Circ Heart Fail. 2023 Jun;16(6):e010173. doi: 10.1161/CIRCHEARTFAILURE.122.010173. Epub 2023 May 11. Circ Heart Fail. 2023. PMID: 37165901 Clinical Trial.
BACKGROUND: Early cardiac allograft vasculopathy (CAV) prognostication is needed to improve long-term outcomes after heart transplantation. We characterized first year posttransplant coronary anatomic-physiologic alterations to determine predictors of early CAV progression …
BACKGROUND: Early cardiac allograft vasculopathy (CAV) prognostication is needed to improve long-term outcomes after heart transplant …
Utility of a smartphone application in assessing palmar circulation prior to radial artery harvesting for coronary artery bypass grafting: rationale and design of the randomised CAPITAL iRADIAL-CABG trial.
Goh CY, Parlow S, Di Santo P, Simard T, Jung R, Ahmed Z, Verreault-Julien L, Kuhar P, Chan V, Al-Atassi T, Toeg H, Bernick J, Wells GA, Ruel M, Hibbert B. Goh CY, et al. Among authors: wells ga. BMJ Open. 2022 Apr 8;12(4):e055580. doi: 10.1136/bmjopen-2021-055580. BMJ Open. 2022. PMID: 35396289 Free PMC article.
The SVG is generally used in its place when this occurs, resulting in potentially lower rates of long-term graft patency. METHODS AND ANALYSIS: The CAPITAL iRADIAL-CABG trial is currently enrolling participants 18 years of age or older undergoing CABG for whom the treating …
The SVG is generally used in its place when this occurs, resulting in potentially lower rates of long-term graft patency. METHODS AND …
Influence of preoperative frailty on quality of life after cardiac surgery: Protocol for a systematic review and meta-analysis.
Bezzina K, Fehlmann CA, Guo MH, Visintini SM, Rubens FD, Wells GA, Mazzola R, McGuinty C, Huang A, Khoury L, Boczar KE. Bezzina K, et al. Among authors: wells ga. PLoS One. 2022 Feb 4;17(2):e0262742. doi: 10.1371/journal.pone.0262742. eCollection 2022. PLoS One. 2022. PMID: 35120151 Free PMC article.
Secondary outcomes will include readmission during the year following the index intervention, discharge to a long-term care facility and living in a long-term care facility at one year. ...
Secondary outcomes will include readmission during the year following the index intervention, discharge to a long-term care facility …
Sex Differences in Implantation and Outcomes of Cardiac Resynchronization Therapy in Real-World Settings: A Systematic Review of Cohort Studies.
Dewidar O, Dawit H, Barbeau V, Birnie D, Welch V, Wells GA. Dewidar O, et al. Among authors: wells ga. CJC Open. 2021 Sep 9;4(1):75-84. doi: 10.1016/j.cjco.2021.09.003. eCollection 2022 Jan. CJC Open. 2021. PMID: 35072030 Free PMC article. Review.
Men received CRT more frequently than women (median ratio, 3.16; 25th to 75th interquartile range, 2.48-3.62). In the unadjusted analysis, men had a greater long-term all-cause mortality rate after CRT, compared with women (hazard ratio [HR], 1.50; 95% confidence interval …
Men received CRT more frequently than women (median ratio, 3.16; 25th to 75th interquartile range, 2.48-3.62). In the unadjusted analysis, m …
Prognostic durability of coronary computed tomography angiography.
Chow BJW, Yam Y, Small G, Wells GA, Crean AM, Ruddy TD, Hossain A. Chow BJW, et al. Among authors: wells ga. Eur Heart J Cardiovasc Imaging. 2021 Feb 22;22(3):331-338. doi: 10.1093/ehjci/jeaa196. Eur Heart J Cardiovasc Imaging. 2021. PMID: 33111135
CCTA has diagnostic and prognostic value but data supporting its long-term prognostic value in a large prospectively recruited cohort with suspected coronary artery disease (CAD) has been limited. ...
CCTA has diagnostic and prognostic value but data supporting its long-term prognostic value in a large prospectively recruited cohort …
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, Hsieh SC, Bai Z, Hossain A, Skidmore B, Tsakonas E, Chojecki D, Mamdani M, Wells GA. Elliott J, et al. Among authors: wells ga. PLoS One. 2020 Oct 21;15(10):e0240584. doi: 10.1371/journal.pone.0240584. eCollection 2020. PLoS One. 2020. PMID: 33085721 Free PMC article.
Furthermore, the certainty of the evidence was very low to low for all outcomes, and there was limited reporting of long-term adverse events. As such, the choice between ADHD pharmacotherapies may depend on individual patient considerations, and future studies should asses …
Furthermore, the certainty of the evidence was very low to low for all outcomes, and there was limited reporting of long-term adverse …
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group.
Nielsen SM, Uggen Rasmussen M, Boers M, A van der Windt D, de Wit M, G Woodworth T, A Flurey C, Beaton D, Shea B, Escorpizo R, Furst DE, Smolen JS, Toupin-April K, Boonen A, Voshaar M, Ellingsen T, Wells GA, Reeves BC, March L, Tugwell P, Christensen R. Nielsen SM, et al. Among authors: wells ga. Ann Rheum Dis. 2021 Feb;80(2):242-249. doi: 10.1136/annrheumdis-2020-217895. Epub 2020 Oct 14. Ann Rheum Dis. 2021. PMID: 33055082
OBJECTIVES: The Outcome Measures in Rheumatology Initiative established the Contextual Factors Working Group to guide the understanding, identification and handling of contextual factors for clinical trials. In clinical research, different uses of the term 'contextual fact …
OBJECTIVES: The Outcome Measures in Rheumatology Initiative established the Contextual Factors Working Group to guide the understanding, ide …
Sex differences after coronary artery bypass grafting with a second arterial conduit.
Rubens FD, Wells GA, Coutinho T, Eddeen AB, Sun LY. Rubens FD, et al. Among authors: wells ga. J Thorac Cardiovasc Surg. 2022 Feb;163(2):686-695.e10. doi: 10.1016/j.jtcvs.2020.04.058. Epub 2020 Apr 23. J Thorac Cardiovasc Surg. 2022. PMID: 32493659 Free article.
However, among women, a double arterial conduit was associated with an increased rate of 30-day death (hazard ratio, 1.48; 95% confidence interval, 1.23-1.79) and major adverse cardiac and cerebrovascular events (hazard ratio, 1.32; 95% confidence interval, 1.14-1.51). The risk o …
However, among women, a double arterial conduit was associated with an increased rate of 30-day death (hazard ratio, 1.48; 95% confidence in …
Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis.
Elliott J, McCoy B, Clifford T, Potter BK, Wells GA, Coyle D. Elliott J, et al. Among authors: wells ga. Pharmacoeconomics. 2020 Sep;38(9):971-980. doi: 10.1007/s40273-020-00923-5. Pharmacoeconomics. 2020. PMID: 32406036
INTRODUCTION: Cannabinoid oils are being increasingly used to treat Dravet syndrome, yet the long-term costs and outcomes of this approach are unknown. Thus, we examined the cost effectiveness of cannabinoid oil as an adjunctive treatment (added to clobazam and valproate), …
INTRODUCTION: Cannabinoid oils are being increasingly used to treat Dravet syndrome, yet the long-term costs and outcomes of this app …
63 results